Advertisement

Topics

Dongbao Enterprise Group Co., Ltd Company Profile

01:11 EDT 19th June 2018 | BioPortfolio

Founded in 1985, Dongbao Enterprise Group Co., Ltd. is a conglomerate industrial group, with more than 20 subsidiaries, actively engaged in the field of pharmaceutical production and is now one of the pioneering manufacturers of recombinant biopharmaceuticals, especially recombinant human insulin.After years' development, the company retains its strength in the field of Traditional Chinese Medicine, and also becomes strong in the production of various types of pharmaceutical formulatios.
In Dongbao, innovative R&D programs, state-of-art technologic facilities, rigorous quality control systems, effectual marketing strategies as well as satisfactory after-sales services have been integrated into a well organized business operation syste.
Since its establishment, Dongbao Group has demonstrated its commitment to improving people's life and adding good value to the society. Due to its achievements, Dongbao is enjoying a sound international recognition today and has established tight partnerships with companies from various countries and will endeavor to further its international collaboration.
In human history, 18 years may not be a long time. What Dongbao has achieved in such a short time is becoming a well established pharmaceutical and biotech group with advanced technological capability, immense growing potential and well defined future prospects.

Location

Room 1906~1909, Shanghai Times Square, 93 Huaihai Road
Shanghai
200021
China

Contact

Phone: 86 21 63910001
Fax: 86 21 63910056
Email: info@dongbao.com


News Articles [709 Associated News Articles listed on BioPortfolio]

Dongbao Pharma Acquires Two Diabetes Treatments in $135 Million Deal

Tonghua Dongbao Pharma acquired China rights to two diabetes treatments from Adocia of Lyon, France in an agreement worth up to $135 million. Dongbao will have rights to BioChaperone® Combo, a fix...

French Insulin Maker Spurned by Eli Lilly Forges Deal with China’s Tonghua Dongbao

Shares of Adocia are up nearly 30 percent this morning after the company announced it granted exclusive development and commercialization rights of its insulin products to Tonghua Dongbao Pharmaceutic...

Tonghua Dongbao to develop, manufacture & commercialize Adocia's BioChaperone Combo & BioChaperone Lispro in China

Adocia, a clinical─stage biotechnology company, and Tonghua Dongbao Pharmaceuticals announced a strategic partnership whereby Adocia granted exclusive development and commercialization rights to To...

BLACKSTAR ENTERPRISE GROUP, INC. Announces:

BLACKSTAR ENTERPRISE GROUP, INC. Incorporated a subsidiary called Crypto Equity Management Corp. BlackStar is conducting an in-depth analysis for the Company's involvement in Distributed Ledger ...

Adocia and Tonghua Dongbao Announce Global Supply Agreements for Insulin Lispro and Insulin Glargine

Tonghua Dongbao (THDB) will manufacture and supply insulin glargine and insulin lispro to Adocia worldwide, excluding China These agreements expand the previously announced strategic alliance betw...

Enterprise: The Best Aircraft Carrier the Navy Ever Built?

Shortly before USS Enterprise went to the breakers, a new ship bearing the name was laid down; CVN-65, the world’s first nuclear aircraft carrier. The latter USS Enterprise served for fifty ye...

Enterprise and Navigator Plan US Ethylene Terminal

US oil and gas company Enterprise Products Partners and UK shipping group Navigator Holdings have formed a 50:50 joint venture to build a 1 million t/y ethylene export terminal on the US Gulf Coast.

Biotech startup developing carbon monoxide poisoning antidote closes $5M Series A

The Tus Science & Technology Service Group, an enterprise group in China, led the Series A round with participation from the commercialization arm of University of Pittsburgh Medical Center ...

PubMed Articles [1853 Associated PubMed Articles listed on BioPortfolio]

Comparison of postsurgical clinical sequences between completely embolized and incompletely embolized patients with wide nicked intracranial aneurysms treated with stent assisted coil embolization technique: A STROBE-compliant study.

The technique of stent-assisted coil embolization has been widely used in the clinic, while its efficacy and safety have yet to be evaluated. This study investigates the values of computed tomography ...

Study on the ownership balance and the efficiency of mixed ownership enterprises from the perspective of heterogeneous shareholders.

Based on the database data of Chinese industrial enterprises from 2000 to 2007 and the LP method, this paper measures the total factor productivity of enterprises and investigates the effect of differ...

Differentiating the effect of social enterprise activities on health.

An emerging stream of literature has focused on the ways in which social enterprises might act on the social determinants of health. However, this previous work has not taken a sufficiently broad acco...

ERM for Health Care Organizations: An Economic Enterprise Risk Management Innovation Program (ERM).

In recent years, health care organizations have looked to enterprise risk management (ERM) for novel systems to obtain more accurate data on which to base risk strategies.

Flow diversion via LVIS Blue-within-an-Enterprise in patients with vertebral artery dissecting aneurysm.

A new Low-profile Visualized Intraluminal Support device (LVIS Blue) is a braided stent that provides a higher degree of metal coverage. This stent may be beneficial for complete obliteration of an an...

Clinical Trials [3710 Associated Clinical Trials listed on BioPortfolio]

Enterprise Stent Implantation in the Treatment of Carotid Artery Stenosis With Ischemic Stroke

To investigate the long-term effects of intracranial implantation of Enterprise stent system versus antiplatelet medication on neurologic deficits, daily living abilities, and carotid arte...

The ENTERPRISE Study - Study of the Enterprise Self-Expanding Stent System

To evaluate the safety and feasibility of the Cordis Neurovascular Self-Expanding Stent System to facilitate endovascular coil embolization of wide neck saccular intracranial aneurysms. ...

The Registry to Study Safety and Performance of the CORDIS Vascular Reconstruction Device and Delivery System

The objective of the registry is to evaluate the real world safety and performance of the CORDIS ENTERPRISE™ Vascular Reconstruction Device and Delivery System (VRD) to facilitate endova...

Study of the Enterprise Self-Expanding Stent System With Endovascular Coil Embolization of Wide- Neck Saccular Intracranial Artery Aneurysms

Cordis Self Expanding Stent for use with embolic coils for the treatment of wide-neck, intracranial, saccular aneurysms arising from a parent vessel

Trials of Clinical Curative Effect, Follow-up Study and Hemodynamics of Treatment of IA Using Stents

Intracranial aneurysms (IA) regarded the third cause of cerebral vascular disease is the majoy cause of subarachnoid hemorrhage (SAH). The mortality and morbidity account for 22% to 25% in...

Companies [2352 Associated Companies listed on BioPortfolio]

Dongbao Enterprise Group Co., Ltd

Founded in 1985, Dongbao Enterprise Group Co., Ltd. is a conglomerate industrial group, with more than 20 subsidiaries, actively engaged in the field of pharmaceutical production and is now one of the...

Coveo

Coveo is a leader in enterprise search-powered solutions. The Coveo Enterprise Search Platform and Customer Information Access Solutions help organizations generate value from information and knowled...

Siemens Enterprise Communications Group

Public Service Enterprise Group (PSEG)

ServiceNow

ServiceNow is the enterprise IT cloud company. We focus on transforming enterprise IT by automating and standardizing business processes and consolidating IT across the global ent...

More Information about "Dongbao Enterprise Group Co., Ltd" on BioPortfolio

We have published hundreds of Dongbao Enterprise Group Co., Ltd news stories on BioPortfolio along with dozens of Dongbao Enterprise Group Co., Ltd Clinical Trials and PubMed Articles about Dongbao Enterprise Group Co., Ltd for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Dongbao Enterprise Group Co., Ltd Companies in our database. You can also find out about relevant Dongbao Enterprise Group Co., Ltd Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...


Corporate Database Quicklinks



Searches Linking to this Company Record